Rebecca Valentin - Concepedia

Author

Rebecca Valentin

Odense University Hospital ORCID

Also Known As

Michael Asger Andersen, R.X. Valentin, Rebecca Valentin, Valentin, Rebecca

Publications

478

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Amsterdam University Medical Centers AbbVie (United States)University Medical Center Groningen University of California, Los Angeles

About

Rebecca Valentin is an author at Odense University Hospital specializing in medicine, molecular medicine, and mitochondrial function.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	126
2	Cell Biology	1	1	52
3	Immunology	1	1	52
4	Molecular Medicine	1	1	52
5	Pathology	1	1	74

Rebecca Valentin

Publications

300

Citations

H-Index

Page 1

	Year	Citations
Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study Maja Bech Juul, Pernille Hammershoej Jensen, Henriette Engberg, European Journal of Cancer Hematological MalignancyLymphoid NeoplasiaOncologyPathologyAdult T-cell Leukemia-lymphoma	2018	74
Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism Stephen Jun Fei Chong, Kartini Iskandar, Jolin Xiao Hui Lai, Nucleic Acids Research	2020	59
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies Elisa ten Hacken, Rebecca Valentin, Fara Faye Regis, JCI Insight Hematological MalignancyLymphoid NeoplasiaBcl2 DependenceAntiapoptotic DependenciesSpliceosome Modulator	2018	52
Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1) Arnon P. Kater, J Christine Ye, Jose Sandoval‐Sus, Blood	2022	42
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, Blood	2021	37
Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1 Alexey V. Danilov, Bita Fakhri, Farrukh T. Awan, Blood	2024	26
CLL-280 Epcoritamab Induces Deep Responses in Patients With Richter Transformation (RT): Primary Results From the EPCORE CLL-1 Trial Arnon P. Kater, Ann Janssens, Herbert Eradat, Clinical Lymphoma Myeloma & Leukemia	2024	10

Page 1